-
Dana White Confirms Flight to Washington for Trump Meeting on Press Secretary Role
-
NASA Awards $10B Lunar Contract Framework to SpaceX, Blue Origin
-
Dengue Fever Expands Into High Himalayas as Climate Change Warms Nepal
-
Katy Perry Tells Fans Ex-Husband Russell Brand 'Should Be in Jail' During UK Concert
-
IoT Refrigerator Hacks Disrupt Blood Labs and Supermarkets Across Europe and US
-
South African election results renew debate over identity-based voting
-
Post-election pressures complicate US and Israeli decisions on Iran
-
South African voters report smoother local election but declining IEC trust
-
UN members approve talks on treaty protocol against environmental crime
-
Dolly Parton museum and Nashville hotel open after singer’s death
-
Family-run West Sussex beach café prepares for first winter season
-
George and Amal Clooney attend New York political-comedy reading
-
CT scans reveal health and burial clues from Egypt’s Braided Lady mummy
-
British buyers pay substantial premiums for period-home appearance
-
Oxford faces complaints over lecturer’s classroom attire
-
Thomas Markle released to house arrest after child-abuse-image charge
-
Kyren Wilson and John Higgins reach International Championship snooker final
-
Dawn of War 4 developers chose Adeptus Mechanicus for tactical variety
-
New Zealand and Tonga meet for place in Rugby League World Cup final
-
Italy face unbeaten South Africa in Turin Nations Championship match
-
Reports of unsafe AI-toy responses renew calls for child-safety rules
-
ChatGPT interactive interface feature tested across six custom tools
-
Juneau food network combines difficult supply routes with deep sharing traditions
-
Freshways milk-price cut deepens pressure on UK dairy farms
-
India climbs green-transition ranking after first emissions decline in 25 years
-
Labour and National remain virtually tied as New Zealand vote count advances
-
Trump names Stephen Miller as White House chief of staff after midterm losses
-
The Good Daughter adapts Karin Slaughter thriller with Rose Byrne and Meghann Fahy
-
Restored Albanian tower houses anchor new rural tourism trail
-
Heavy-lift drone evacuates wounded Ukrainian soldier from frontline kill zone
-
Sonia Gandhi reflects on family tragedy and reluctant political career
-
Morrison says West Brom recovered after pressure from successive derby losses
-
Pope Leo begins three-country South American tour in Uruguay
-
Britain considers 2027 state visit for Ukraine’s Zelensky
-
Khawaja says entire Australia camp knew of 2018 ball-tampering plan
Scientists clone first rhesus monkey using new method
Scientists in China on Tuesday announced that they have cloned the first healthy rhesus monkey, a two-year-old named Retro, by tweaking the process that created Dolly the sheep.
Primates have proved particularly difficult to clone, and the scientists overcame years of failure by replacing the cloned cells that would become the placenta with those from a normal embryo.
They hope their new technique will lead to the creation of identical rhesus monkeys that can be experimented on for medical research.
However, outside researchers warned that the success rate for the new method was still very low, as well as raising the usual ethical questions around cloning.
Since the historic cloning of Dolly the sheep using a technique called somatic cell nuclear transfer (SCNT) in 1996, more than 20 different animals have been created using the process, including dogs, cats, pigs and cattle.
However it was not until two decades later that scientists managed to clone the first primates using SCNT.
A pair of identical crab-eating macaques named Hua Hua and Zhong Zhong were created using SCNT in 2018 by researchers at the Chinese Academy of Sciences Institute of Neuroscience in Shanghai.
But that breakthrough, led by the institute's Qiang Sun, only resulted in live births in fewer than two percent of attempts.
Qiang was also a senior author of the new research published in the journal Nature Communications.
He told AFP that the team had extensively researched why previous efforts to clone the rhesus monkey (Macaca mulatta) had failed.
In an earlier attempt, one monkey -- out of 35 implanted foetuses -- was born alive, but it died in less than a day.
Qiang said that one of the "major problems" was that the placentas of cloned embryos were showing abnormalities compared to those from in vitro fertilisation.
So the researchers replaced the cells that later become the placenta, which are called the trophoblast, with those from a healthy, non-cloned embryo.
The trophoblast cells provide nutrients to a growing embryo, and turn into the placenta that supplies oxygen and other life-supporting assistance to the foetus.
The technique "greatly improved the success rate of cloning by SCNT" and led to the birth of Retro, Qiang said.
- Human cloning 'unacceptable' -
However Lluis Montoliu, a scientist at the Spanish National Centre for Biotechnology who was not involved in the research, pointed out that just one out of 113 initial embryos survived, meaning a success rate of less than one percent.
If human beings were to ever be cloned -- the great ethical fear of this field of research -- then other primate species would have to be cloned first, he said.
But so far, the poor efficiency of these efforts has "confirmed the obvious: not only was human cloning unnecessary and debatable, but if attempted, it would be extraordinarily difficult -- and ethically unjustifiable," Montoliu said.
Qiang emphasised that cloning a human being was "unacceptable" in any circumstance.
For the SCNT procedure, scientists remove the nucleus from a healthy egg, then replace it with another nucleus from another type of body cell.
The embryo therefore grows into the same creature that donated the replacement nucleus.
A rhesus monkey named Tetra was cloned in 1999 using a different technique called embryo splitting.
But this simpler technique can only produce four clones at once.
Scientists have focused on SCNT in part because it can create far more clones, with the goal of creating identical monkeys to study a range of diseases as well as test drugs.
Y.Kobayashi--AMWN